A novel in vitro assay correlates insulin receptor autoantibodies to fasting insulin in type B insulin resistance.
Waldemar B MinichBrent S AbelChristian SchwiebertTim WelsinkPetra SeemannRebecca J BrownLutz SchomburgPublished in: The Journal of clinical endocrinology and metabolism (2023)
Quantification of InsR-aAb from serum samples via the novel in vitro assay enables identification of TBIR and monitoring of successful therapy.